Maternal anemia and hemato-oncology in pregnancy

2005 ◽  
pp. 43-65
Keyword(s):  
2013 ◽  
Vol 121 (2) ◽  
pp. 103-109 ◽  
Author(s):  
Elizabeth M. McClure ◽  
Robert L. Goldenberg ◽  
Arlene E. Dent ◽  
Steven R. Meshnick

2013 ◽  
Vol 88 (2) ◽  
pp. 292-300 ◽  
Author(s):  
Smaïla Ouédraogo ◽  
Manfred M. K. Accrombessi ◽  
Florence Bodeau-Livinec ◽  
Ghislain K. Koura ◽  
Michel Cot ◽  
...  

Author(s):  
Desy Meldawati

Postpartum depression is a depression syndrome that occurs in mothers after childbirth and can be prevented and cured. According to Fazraningtyas, in South Kalimantan, to be precise in the city of Banjarmasin, namely Ulin General Hospital of Banjarmasin and Dr. H.M. Ansari Saleh General Hospital of Banjarmasin showed 56.8% mild postpartum depression, 26.1% moderate postpartum depression, 17.0% severe postpartum depression. The impact of mothers experiencing postpartum depression is that mothers have difficulty interacting and can endanger their children. Postpartum depression is caused by several factors, the factors that contributed are complications in pregnancy. This study used a literature review approach. The articles obtained from Google Scholar, Biomed Central, and Pubmed. The criterias applied be restricted. As many as 10 journals are found. Based on the previous study, complications in pregnancy are the cause of postpartum depression. Complications that are often experienced by pregnant women are maternal anemia that can appear during the pregnancy process until the birth process occurs and 30-70% of pregnant women with maternal anemia have a risk of postpartum depression. Second, gestational diabetes is one of the complications of pregnancy that occurs in women who are pregnant. Pregnant women can increase hormones including the progesterone hormone, human placental lactogen estrogen, and cortisol. The last, a history of depression is a cause of postpartum depression because if pregnant women have a history of depression before pregnancy, they will have a higher risk of experiencing postpartum depression.


2016 ◽  
Vol 133 (3) ◽  
pp. 284-286 ◽  
Author(s):  
Eram Ali ◽  
Manisha Kumar ◽  
Sayyed E.H. Naqvi ◽  
Shubha S. Trivedi ◽  
Anuradha Singh

2018 ◽  
Vol 08 (07) ◽  
pp. 676-687
Author(s):  
Mohamed Abdelaziz Youssry ◽  
Ahmed Mohamed Radwan ◽  
Mohamed Amin Gebreel ◽  
Tabarak Ahmed Patel

Author(s):  
Rachel Lau ◽  
Robert B Chris ◽  
Melissa S Phuong ◽  
Aisha Khatib ◽  
Swana Kopalakrishan ◽  
...  

Abstract Background Gestational helminth infections are correlated to adverse outcomes including maternal anemia; as such, treatment is recommended. However, little published high-quality data exist around the efficacy, safety, and tolerability of anti-helminthics in pregnancy. We therefore conducted a systematic review and synthesized the available data on maternal outcomes following gestational treatment of intestinal nematodes to help guide clinical decision-making. Methods Five electronic databases were searched for studies reporting the efficacy, safety, or tolerability of anti-helminthic drugs for gestational treatment of intestinal nematodes. Studies were systematically screened, followed by data extraction. Trial quality was assessed using the GRADE approach. We conducted a narrative synthesis followed by meta-analyses using random-effects models as appropriate. Data were summarized using qualitative and quantitative measures for specific parasitic infections as well as efficacy and safety of anti-parasitic agents. Outcomes of interest included: maternal anemia, minor adverse outcomes, pregnancy loss, pre-mature delivery, prevalence of infection, and cure rate. Results 23 studies were included. Gestational treatment with albendazole had cure rates up to 90% for hookworm and Ascaris, but only 50% for Trichuris. Mebendazole had an overall cure rate of ≤70% for Ascaris, hookworm, and Trichuris. Pooled relative risk reduction of hookworm prevalence at delivery with albendazole compared to placebo was 90% (95%CI 0.09-0.15, n=2, I2=0%). Rate of pregnancy loss and hemoglobin concentration did not differ between albendazole or mebendazole versus placebo, and rates of pre-term delivery were similar in albendazole-treated pregnant women versus controls. Ivermectin demonstrated a cure rate of 29% for hookworm and 56% for Trichuris in pregnant women. No serious adverse events were attributable to any drug studied. Conclusions With increased international travel and migration of vulnerable populations, practitioners will encounter nematode infections in pregnant patients. Our analysis supports that albendazole in pregnancy has high cure rates for STHs and is safe for the mother.


Author(s):  
Puspendu Biswas ◽  
M. Samsuzzaman ◽  
Amitava Chakraborty ◽  
Dilip Kumar Das

Background: Being both highly prevalent public health problems in India, anemia in pregnancy (AIP) is hypothesized as a potential risk factor for low birth weight (LBW) baby as pregnancy outcome. In this context, this study was conducted among pregnant mothers registered in last 2 years under Bhatar block of Purba Bardhaman district, West Bengal. Objectives of this study were to assess the relationship of LBW babies with maternal anemia in antenatal period and also with background characteristics and pregnancy related factors.Methods: A retrospective cohort analysis was conducted among postnatal mothers who were registered during their pregnancy in sub-centers of this block during a reference period from April’15th - March’17th. The study subjects were identified from the records of each sub-centre and further categorized into two groups: Exposed (anemic) - Hb <11 gm% in any antenatal visits and Non-exposed(non-anemic) - Hb ≥11 gm% in all antenatal visits. Sample size of 988 for each group was calculated. From each sub-centre’s antenatal record 26 subjects for each group were selected by simple random sampling. Data collected with predesigned pretested schedule and data analyzed using Microsoft Excel and SPSS 20. Logistic regression was performed to establish association.Results: Overall incidence of LBW was 8.1%; in anemic, non-anemic group incidence were 10.5%, 5.7% respectively. AIP had relative risk 1.85 (1.36-2.54) over LBW. On multivariable logistic regression, LBW was significantly associated with AIP (2.11, 1.51-2.95), multi-parity (0.63, 0.44-0.9), inadequate ANC visits (2.7, 1.75-4.15) and female gender (1.64, 1.19-2.27).Conclusions: Anemia in pregnancy significantly increases risks of LBW which also strongly associated with female new-born, primi-parity, and incomplete ANC visits.


2013 ◽  
Vol 13 (1) ◽  
Author(s):  
Cristiane Campello Bresani ◽  
Maria Cynthia Braga ◽  
Daniel Falcão Felisberto ◽  
Carlos Eduardo Lopes Tavares-de-Melo ◽  
Debora Bresani Salvi ◽  
...  

2022 ◽  
Vol 19 (1) ◽  
pp. 30-33
Author(s):  
Jyoti Adhikari ◽  
Mohan Belbase ◽  
Shikha Rijal

Introduction: Anemia is one of the most prevalent nutritional deficiency problem affecting pregnant women. It is defined by World Health Organization as hemoglobin (Hb) level of less than 11 g/dl. Hemoglobin level of 9.0- 10.9 g/dl is mild, 7.0-8.9 g/dl is moderate and less than 7 g/dl is severe anemia respectively. Maternal anemia in pregnancy is commonly considered as a risk factor for poor pregnancy outcome and can result in complications that threaten the life of both mother and fetus. Aims: To find out neonatal outcome delivered to anemic mothers. Methods: A prospective case control study was carried out among 75 newborns delivered to pregnant women with hemoglobin below 10.9g/dL. Another 75 newborns were taken delivered at the same time, matched age and sex wise as a control group to mothers whose hemoglobin was more than 11g/dl. Results: Out of total 75 cases 35(46.7%) mothers had mild, 32(42.6%) had moderate and 8(10.7%) had severe anemia respectively. Similarly, the risk of having preterm baby among anemia group was 4.42 times higher than that in control group (p 0.033). The risk of having low birth weight in anemia group was 3.9 times higher than that in control group (p 0.04). The mean of head circumference (HC) among the anemia group was 33.9cm +1.40 (Mean+SD) and among the control group was 34.4cm+1.24(Mean+SD) with a mean difference of 0.5cm (p 0.032). The mean of length among anemia group was 45.3cm+1.97 (Mean+ SD) and among the control group was 46.2cm+1.69 (Mean+ SD) with a mean difference of 0.9 cm (p 0.003). Conclusion: Maternal anemia in pregnancy is associated with increased risk of adverse neonatal outcome. Efforts must be made to reduce the prevalence of anemia especially during pregnancy to reduce neonatal morbidity and mortality.


Sign in / Sign up

Export Citation Format

Share Document